Postbiotics Food Supplements Market to Reach US$ 35.91 Million by 2035 as Microbiome Nutrition, Immune Support and Shelf-Stable Probiotic Alternatives Gain Momentum

July 12, 2026 - The global postbiotics food supplements market reached US$13.2 million in 2025 and is projected to reach US$35.91 million by 2035, expanding at a CAGR of 10.5% during 2026-2035, according to DataM Intelligence. Postbiotics are emerging as a formulation-led microbiome opportunity because their inanimate nature can provide greater stability, consistency and manufacturing flexibility than live microorganisms. These advantages are helping supplement brands explore differentiated gut health, immune support and healthy-longevity products beyond the increasingly crowded probiotic category.

Request Executive Sample | Market Intelligence: https://www.datamintelligence.com/download-sample/postbiotics-food-supplements-market?kailas

2026 Official Developments in Postbiotics Food Supplements

- Kerry expanded the commercial relevance of PlenibioticTM for GLP-1 users. In February 2026, Kerry published findings from a four-week U.S. consumer-perception study involving 233 GLP-1 users experiencing gastrointestinal symptoms. Plenibiotic is a heat-inactivated, rice-derived postbiotic designed for digestive regularity and gut comfort. Kerry highlighted its stability and suitability for functional beverages, bars, powders and capsules.

- Supplement formats continued moving beyond conventional tablets. Kerry's January 2026 Supplement Taste Charts identified growing demand for Candy, chews, powders and stick packs, with convenience, palatability and scientific evidence becoming important purchase considerations. This format transition strengthens the opportunity for stable microbiome ingredients that can tolerate varied processing and storage conditions.

- dsm-firmenich connected microbiome balance with healthy longevity. At Vitafoods Europe 2026, the company presented its "Longevity Shift" platform, which addresses gut dysbiosis as a hallmark of aging. Its approach combines prebiotics, probiotics and postbiotics to support microbiome balance and gut resilience, while providing premix, market-ready and product-development services.

- South Korea reinforced its evidence-led functional-ingredient framework. In January 2026, the Ministry of Food and Drug Safety published its English reference version of the regulation governing recognition of functional ingredients and standards for health functional foods. The framework underscores the importance of ingredient characterization, specifications and regulatory substantiation for products entering the Korean market.
Stability Is Becoming a Commercial Differentiator

Unlike conventional probiotics, postbiotics do not depend on maintaining viable microorganisms through manufacturing, transport, storage and consumption. This can reduce cold-chain dependence and improve consistency across capsules, Candy, powders, functional beverages and private-label formulations.

DataM Intelligence identifies stability, microbiome awareness, preventive nutrition and growing demand for gut and immune health products as central market drivers. Postbiotics may also be easier to standardize because manufacturers can define the microbial strains, cell components and metabolites present in the finished ingredient.

The opportunity extends beyond replacing probiotics. Postbiotic supplements can be positioned as part of broader microbiome-support portfolios addressing digestive comfort, immune resilience, skin health, weight management, mental well-being and healthy aging.

Request a Customized Report According to Your Business Strategy: https://www.datamintelligence.com/customize/postbiotics-food-supplements-market?kailas

Claim Substantiation Remains the Primary Market Barrier

Commercial growth will depend on whether ingredient suppliers and finished-product companies can translate microbiome science into clearly substantiated consumer benefits. The term "postbiotic" is still unfamiliar to many consumers, creating the risk of confusion with probiotics and prebiotics.

Regulatory treatment also differs by market. In the United States, dietary supplements are regulated as foods rather than medicines and are not approved by the FDA for safety and effectiveness before being marketed. In the European Union, health claims must be scientifically supported and authorized before they are used commercially.

This environment increases the strategic value of human clinical evidence, characterized ingredients, stable manufacturing specifications and carefully reviewed product language.

Market Opportunities Across Formats and Applications

Postbiotics are particularly suitable for product categories in which live-culture survival can be difficult. Emerging opportunities include:
- Digestive-health capsules and daily powder sachets
- Immune-support candy and chewable supplements
- Functional beverages, nutrition bars and fortified foods
- Private-label microbiome formulations
- Products supporting healthy aging and metabolic wellness

Their processing flexibility could allow manufacturers to introduce microbiome benefits into mainstream nutrition formats without requiring refrigeration or highly controlled distribution.

Postbiotics Food Supplements Market Segmentation
Capsules and Tablets

Capsules and tablets remain strategically important because they support accurate dosing, ingredient protection and familiar daily-use routines. They are well suited to clinically positioned postbiotic supplements targeting digestive health, immunity and general wellness. The format also enables combinations with prebiotics, vitamins, minerals and botanical ingredients.

Powder and Liquid Formulations

Powders and liquids are expected to support faster innovation because they can be incorporated into drink mixes, stick packs, functional beverages and personalized nutrition systems. Postbiotic stability may provide an important advantage in these applications, particularly where heat, moisture or extended shelf life would create challenges for live probiotic strains.

DataM segments the market by type, form, application and distribution channel. Applications include digestive health, immune support, skin health, weight management, sports nutrition, mental health and general wellness.

Regional Market Outlook
Asia-Pacific and Japan

Asia-Pacific leads the market, supported by established consumer familiarity with fermented foods, gut-health products and functional nutrition. Japan offers a particularly attractive evidence-led environment through its Foods with Function Claims, FOSHU and nutrient-function systems. Under the Foods with Function Claims framework, businesses remain responsible for supporting the safety and scientific basis of communicated functions.

North America and the United States

North America is identified as the fastest-growing region. The United States offers strong potential for supplement innovation, direct-to-consumer brands, private-label manufacturing and functional nutrition launches. However, ingredient identity, labelling, manufacturing controls and structure-function claims must remain aligned with FDA requirements.

Europe and Germany

Germany offers opportunities for evidence-led digestive-health and immune-support formulations, but European claim rules create a high substantiation threshold. Products must be designed around authorized language, clearly characterized ingredients and documentation capable of supporting regulatory review.

South Korea

South Korea combines strong demand for gut health, functional foods and beauty-from-within concepts with formal functional-ingredient recognition requirements. Postbiotic suppliers that connect microbiome support with skin, immunity or healthy-aging applications may find attractive opportunities, provided claims and specifications meet MFDS requirements.

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=postbiotics-food-supplements-market

Competitive Landscape and Selected Company Profiles

ADM provides heat-treated microbiome ingredients including Bifidobacterium longum CECT 7347 HT-ES1 and Lactobacillus gasseri CP2305. Its portfolio supports digestive, immune, stress, mood and sleep-related formulation concepts. ADM's global nutrition capabilities and formulation services make it strategically important for brands seeking to integrate postbiotics into foods, beverages and dietary supplements.

Cargill supplies EpiCor®, a fermented Saccharomyces cerevisiae postbiotic positioned for immune and gut health. The ingredient has been evaluated in more than 15 published studies, can be formulated into dietary supplements and adult nutrition products, and offers a three-year shelf life. Its U.S. manufacturing and broad application flexibility support North American and international product development.

dsm-firmenich offers Humiome® Post LB, combining proprietary lactobacillus strains, metabolites and fermented culture medium. Its heat-stabilized composition is designed for consistency, transport and storage. The company also provides premix development, market-ready solutions, scientific support and formulation services across global supplement markets.

Novonesis, formed through the combination of Chr. Hansen and Novozymes, supports human-health innovation with an extensive microbial-strain library and product-development capabilities. Its PylopassTM powder-format postbiotic is based on Limosilactobacillus reuteri and is positioned to support microbial balance and gastric health.

Product Innovation Outlook

The next phase of the postbiotics food supplements market will be defined by clinically differentiated ingredients rather than category terminology alone. Products that combine stability with transparent strain identification, validated benefits, convenient formats and legally supportable claims will be better positioned to secure retailer, private-label and consumer confidence.

As microbiome supplements expand into candy, beverages, personalized nutrition and longevity-positioned formulations, postbiotics could become an important bridge between scientific ingredient development and accessible everyday nutrition.

About DataM Intelligence

DataM Intelligence provides market intelligence, competitive analysis and customized research across food and beverages, dietary supplements, healthcare, medical technology and other global industries.

Read Exclusive Report Description: https://www.datamintelligence.com/research-report/postbiotics-food-supplements-market

Contact:
Fabian Mathew
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: fabian@datamintelligence.com

About DataM Intelligence
DataM Intelligence is a global market research and business intelligence firm delivering actionable insights across healthcare, pharmaceuticals, chemicals, energy, technology, food, and industrial sectors. Through syndicated reports, custom research, consulting, and competitive intelligence services, the company helps organizations identify growth opportunities, navigate market challenges, and make informed strategic decisions in over 50+ countries worldwide.

This release was published on openPR.